Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy (Q41167388)
Jump to navigation
Jump to search
scientific article published on 12 September 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy |
scientific article published on 12 September 2012 |
Statements
1 reference
Long-term nonprogressor and elite controller patients who control viremia have a higher percentage of methylation in their HIV-1 proviral promoters than aviremic patients receiving highly active antiretroviral therapy (English)
1 reference
Juan Antonio Palacios
1 reference
Teresa Pérez-Piñar
1 reference
Carlos Toro
1 reference
Beatriz Sanz-Minguela
1 reference
Victoria Moreno
1 reference
Eulalia Valencia
1 reference
César Gómez-Hernando
1 reference
Berta Rodés
1 reference
12 September 2012
1 reference
1 reference
Identifiers
1 reference